Company: RVRC
Filing Date: 2025-10-03
Form Type: S-1/A
Source: 0001213900-25-096094
Chunk: 241

Company: Revium Rx.
Filing Date: 2025-10-03
Form: S-1/A
Chunk 241
---
                                                                                                             
 of Common Stock and 35,538 Exchange Shares issued to the Selling Stockholder on July 23, 2024.                                         |
| 31 | Represents  Exchange                                                                                                                   
 Shares issued to the Selling Stockholder on July 23, 2024.                                                                             |
| 32 | Represents  Exchange                                                                                                                   
 Shares issued to the Selling Stockholder on July 23, 2024.                                                                             |
| 33 | Consists of 792,545 shares                                                                                                             
 of Common Stock and 323,070 Exchange Shares issued to the Selling Stockholder on July 23, 2024.                                        |
| 34 | Represents Exchange Shares                                                                                                             
 issued to the Selling Stockholder on July 23, 2024.                                                                                    |
| 35 | Represents Exchange Shares                                                                                                             
 issued to the Selling Stockholder on July 23, 2024.                                                                                    |
| 36 | Represents Exchange Shares                                                                                                             
 issued to the Selling Stockholder on July 23, 2024.                                                                                    |
| 37 | Represents Exchange Shares                                                                                                             
 issued to the Selling Stockholder on July 23, 2024.                                                                                    |

Material Relationships with Selling Stockholders.

Other than as disclosed above, none of the Selling
Stockholders has had a material relationship with us or any of our affiliates other than as a stockholder at any time within the past
three years.

<div align='center'>Alt-5

[RESALE PROSPECTUS ALTERNATE PAGE]

USE OF PROCEEDS</div>

All shares of our Common
Stock offered by this Resale Prospectus are being registered for the account of the Selling Stockholders identified herein. We will not
receive any of the proceeds from the sale of these shares.

We will receive proceeds
from any cash exercise of the Investor Warrants, which, if exercised in cash with respect to all of the 6,372,265 shares of common stock
underlying the Investor Warrants, would result in gross proceeds to us of a maximum of approximately $7,413,436.

We intend to use any
proceeds received by us from the cash exercise of the Investor Warrants for working capital purposes. As of the date of this prospectus,
we cannot specify with certainty all of the particular uses for the net proceeds to us from the cash exercise of the Investor Warrants.
Accordingly, our management will have broad discretion in the timing and application of these proceeds. The holders of the Investor Warrants
may exercise the Investor